Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1)

Genetics and Molecular Biology

Volumn 35, Issue 2, 2012, Pages 538-544

  Zhu, Xiang Yu ^a   Liu, Ning ^a   Liu, Wei ^a   Song, Shao Wei ^a   Guo, Ke Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

E cadherin; Epithelial mesenchymal transition (EMT); Integrin linked kinase (ILK); Panc 1 cell line; RNA interference (RNAi)

Indexed keywords

INTEGRIN LINKED KINASE; MESSENGER RNA; SMALL INTERFERING RNA; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CYCLE G0 PHASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTEGRIN LINKED KINASE GENE; MARKER GENE; PANCREAS CANCER; PANCREAS DUCT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR GENE; UPREGULATION;

LENTIVIRUS;

EID: 84863652433     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572012005000028     Document Type: Article

References (18)

1. Ahmed N, Oliva K, Rice GE and Quinn MA (2004) Cell-free 59 kDa immunoreactive integrin-linked kinase: A novel narker for ovarian carcinoma. Clin Cancer Res 10:2415-2420.
2. Barnes EA, Kenerson HL, Jiang XY and Yeung RS (2010) Tuberin regulates e-cadherin localization: Implications in epithelial-mesenchymal transition. Am J Pathol 177:1765-1778.
3. Brakebusch C and Fassler R (2003) The integrin-actin connection, an eternal love affair. EMBO J 22:2324-2333.
4. Chen H, Tu H, Meng ZQ, Chen Z, Wang P and Liu LM (2010) K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer. Eur J Surg Onc 36:657-662.
5. David M and Parham MD (2001) Neuroectodermal and neuroendocrine tumors principally seen in children. Am J Clin Pathol 115:S113-S128.
6. Giancotti FG and Ruoslahti E (1999) Integrin signaling. Science 13:1028-1032.
7. Gunaratnam NT, Sarma AV, Norton MID and Wiersema MJ (2001) A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 54:316-324.
8. Hannigan G, Troussard AA and Dedhar S (2005) Integrin-linked kinase: A cancer therapeutic target unique among its ILK. Nat Rev Cancer 5:51-63.
9. Hariharan D, Saied A and Kocher HM (2008) Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 10:58-62.
10. Kang YB and Massague J (2004) Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118:277-279.
11. Kumar AS, Naruszewicz I, Wang P, Leung-Hagesteijin CL and Hannigan GE (2004) ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 23:3454-3461.
12. Matsui Y, Assi K, Ogawa O, Raven PA, Dedhar S, Gleave ME, Salh B and So AI (2012) The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int J Cancer 130:521-531.
13. Ramos-Vara JA (2005) Technical aspects of immunohistochemistry. Vet Pathol 42:405-426.
14. Shaib YH, Davila JA and El-serag HB (2006) The epidemiology of pancreatic cancer in the United States: Changes below the surface. Aliment Pharmacol Ther 24:87-94.
15. Towbin H, Staehelint T and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
16. Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD and Dedhar S (2000) The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19:5444-5452.
17. Yau CY, Wheeler JJ, Sutton KL and Hedley DW (2005) Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res 65:1497-1504.
18. Yoganathan TN, Costello P, Chen XY, Jabali M, Yan J, Zhang ZH, Yee A, Dedhar S and Sanghera J (2000) Integrin/linked kinase (ILK): A "hot" therapeutic target. Biochem Pharmacol 60:1115-1119.